Protagonist Therapeutics News

Company Name Stock Ticker Symbol Market Type
Protagonist Therapeutics Inc PTGX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.05 -9.17% 10.40 20:00:00
Open Price Low Price High Price Close Price Prev Close
11.63 10.34 11.63 10.40 11.45
more quote information »

Recent News

Date Time Source Heading
8/05/202216:34EDGARSecurities Registration Statement (simplified Form) (s-3)
8/04/202216:12EDGARCurrent Report Filing (8-k)
8/04/202216:05PRNUSProtagonist Reports Second Quarter 2022 Financial Results..
7/19/202207:00PRNUSProtagonist Therapeutics Reports Granting of Inducement..
7/11/202211:51EDGARAmended Statement of Ownership (sc 13g/a)
6/10/202211:06EDGARAmended Statement of Ownership (sc 13g/a)
6/01/202216:05PRNUSProtagonist Therapeutics to Participate at the Jefferies..
5/27/202216:12EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202216:11EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202216:08EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202216:04EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202216:04EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202217:10PRNUSProtagonist Therapeutics to Present Updated Phase 2..
5/07/202208:17TRMNJ.P. Morgan Thinks Protagonist Therapeutics’ Stock is Going..
5/06/202206:15TRMNAnalysts Offer Insights on Healthcare Companies: Protagonist..
5/05/202208:40TRMNAnalysts’ Top Healthcare Picks: AxoGen (AXGN), Protagonist..
5/04/202216:05PRNUSProtagonist Reports First Quarter 2022 Financial Results and..
4/26/202223:19TRMNProtagonist Therapeutics (PTGX) Receives a Buy from Leerink..
4/26/202206:20TRMNAnalysts’ Opinions Are Mixed on These Healthcare Stocks:..
4/25/202216:25PRNUSProtagonist Therapeutics Announces Topline Data from Phase 2..
4/19/202219:49EDGARStatement of Changes in Beneficial Ownership (4)
4/19/202219:36EDGARInitial Statement of Beneficial Ownership (3)
4/19/202216:15PRNUSProtagonist Therapeutics Reports Granting of Inducement..
4/14/202223:45TRMNWall Street Analysts Are Bullish on Top Healthcare Picks
4/14/202223:05TRMNLeerink Partners Reaffirms Their Buy Rating on Protagonist..
4/14/202206:49DJNProtagonist Shares Tumble After FDA Says It May Pull..
4/14/202206:16TRMNAnalysts Have Conflicting Sentiments on These Healthcare..
4/13/202217:11EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/13/202217:07EDGARProxy Statement (definitive) (def 14a)
4/13/202216:32EDGARCurrent Report Filing (8-k)
3/31/202216:26EDGARCurrent Report Filing (8-k)
3/29/202222:37TRMNProtagonist Therapeutics (PTGX) Receives a Buy from Leerink..
3/28/202207:30SEEKAsif Ali is the new finance chief at Protagonist..
3/28/202207:06PRNUSProtagonist Therapeutics Announces Appointment of Asif Ali..
3/24/202210:58TRMNProtagonist Therapeutics (PTGX) Gets a Buy Rating from..
3/23/202216:06EDGARCurrent Report Filing (8-k)
3/16/202207:00PRNUSProtagonist Therapeutics Earns $25 Million Milestone Payment..
3/02/202206:27TRMNProtagonist Therapeutics (PTGX) Received its Third Buy in a..
2/28/202218:23EDGARAnnual Report (10-k)
2/28/202217:47EDGARSecurities Registration: Employee Benefit Plan (s-8)
2/28/202217:17SEEKProtagonist GAAP EPS of -$0.77 beats by $0.02, revenue of..
2/28/202216:54EDGARCurrent Report Filing (8-k)
2/28/202216:05PRNUSProtagonist Therapeutics Reports Fourth Quarter and Full..
2/22/202216:32EDGARCurrent Report Filing (8-k)
2/14/202213:57EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202208:08EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202206:11EDGARAmended Statement of Ownership (sc 13g/a)
2/11/202216:53EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202207:00PRNUSProtagonist Therapeutics to Present at the 11th Annual SVB..
2/09/202210:26EDGARAmended Statement of Ownership (sc 13g/a)

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now